Table 5

Baseline values and effect of growth hormone and glutamine (treatment minus baseline) on intestinal absorption and serum insulin-like growth factor 1 (IGF-1) in individual patients with and without a preserved colon

			Intestinal absorption (% of oral intake)
Patient		IGF (ng/ml)		Energy		Carbohydrates		Fat		Wet weight		Sodium
No	Colon	Baseline	Effect^5-150	Baseline	Effect	Baseline	Effect	Baseline	Effect	Baseline	Effect	Baseline	Effect
1	Yes	138	+331	46	+1.8	81	+3.0	−7	+4.1	45	−15.1	62	−7.2
2	Yes	99	+196	51	+1.5	81	+1.0	27	+3.6	55	+1.3	76	−6.7
3	Yes	189	+418	47	−12.2	75	−9.1	44	−38.0	47	−1.1	28	+16.8
4	Yes	93	+344	67	−0.5	84	+0.2	35	−3.5	76	−10.6	49	−14.1
5	No	134	+478	33	+2.0	60	+0.9	−9	+22.1	0	−13.6	−125	−32.2
6	No	205	+462	64	−5.0	79	−2.4	40	−8.3	39	−5.0	−72	−107.1
7	No	254	+633	42	+4.8	65	+0.9	26	−3.9	59	−0.3	2	−16.6
8	No	159	+250	17	+5.4	41	+8.0	1	+6.5	−26	+2.8	−145	+3.2
Mean	Yes	130	+322	53	−2.4	80	−1.2	25	−8.5	56	−6.4	54	−2.8
Mean	No	188	+456	39	+1.8	61	+1.9	15	4.1	18	−4.0	−85	−38.2
p		0.14	0.19	0.26	0.35	0.06	0.41	0.54	0.34	0.11	0.67	0.007	0.21

↵5-150 Effect on IGF, mean IGF (ng/ml) after one, two, and three weeks of active treatment minus IGF at baseline.